PRNewswire: July 20, 2016 – PHILADELPHIA, PA, U.S.A. – Lannett Company, Inc. (NYSE: LCI) today announced that its strategic partner, Sparsha Pharma USA, Inc., has received an acceptable for filing letter from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA…
